4.6 Article

Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Automated Determination of Brain Parenchymal Fraction in Multiple Sclerosis

M. Vagberg et al.

AMERICAN JOURNAL OF NEURORADIOLOGY (2013)

Article Clinical Neurology

CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome

M. Khalil et al.

MULTIPLE SCLEROSIS JOURNAL (2013)

Article Clinical Neurology

A comparative study of CSF neurofilament light and heavy chain protein in MS

Jens Kuhle et al.

MULTIPLE SCLEROSIS JOURNAL (2013)

Article Clinical Neurology

Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples

Tobias Skillback et al.

ALZHEIMERS RESEARCH & THERAPY (2013)

Article Multidisciplinary Sciences

CSF-Biomarkers in Olympic Boxing: Diagnosis and Effects of Repetitive Head Trauma

Sanna Neselius et al.

PLOS ONE (2012)

Article Geriatrics & Gerontology

Brain regional lesion burden and impaired mobility in the elderly

Nicola Moscufo et al.

NEUROBIOLOGY OF AGING (2011)

Article Clinical Neurology

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis

C. E. Teunissen et al.

NEUROLOGY (2009)

Article Clinical Neurology

Neurofilament and glial fibrillary acidic protein in multiple sclerosis

N Norgren et al.

NEUROLOGY (2004)

Article Clinical Neurology

Eight-year follow-up study of brain atrophy in patients with MS

E Fisher et al.

NEUROLOGY (2002)